Eastland Medical Systems (ASX:EMS) Receive Regulatory Approval For Anti-Malaria Treatment

Eastland Medical Systems Ltd (ASX: EMS) remains on track with the development of its anti-malaria treatment ArTiMistTM and will commence a multi dose Phase 1 clinical trial for ArTiMistTM in February, after its Pharmaceutical Division receiving approval from the South African MCC Regulatory Body.

More: continued here

Filed under: Tropical on January 29th, 2008